307 related articles for article (PubMed ID: 25376109)
1. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob R; Bollheimer LC; Bertsch T; Fellner C; Djukic M; Sieber CC; Fischer BE
Biogerontology; 2015 Feb; 16(1):15-29. PubMed ID: 25376109
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
Kalinkovich A; Livshits G
Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
[TBL] [Abstract][Full Text] [Related]
3. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome and Sarcopenia.
Nishikawa H; Asai A; Fukunishi S; Nishiguchi S; Higuchi K
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684520
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review.
Li CW; Yu K; Shyh-Chang N; Jiang Z; Liu T; Ma S; Luo L; Guang L; Liang K; Ma W; Miao H; Cao W; Liu R; Jiang LJ; Yu SL; Li C; Liu HJ; Xu LY; Liu RJ; Zhang XY; Liu GS
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):781-794. PubMed ID: 35106971
[TBL] [Abstract][Full Text] [Related]
6. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
Consitt LA; Clark BC
J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
[TBL] [Abstract][Full Text] [Related]
7. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia and sarcopenic obesity.
Choi KM
Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
[TBL] [Abstract][Full Text] [Related]
9. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity.
Rivas DA; McDonald DJ; Rice NP; Haran PH; Dolnikowski GG; Fielding RA
Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(7):R561-9. PubMed ID: 26764052
[TBL] [Abstract][Full Text] [Related]
10. Role of Nutritional Supplements on Gut-Muscle Axis Across Age: a Mini-Review.
Nucci RAB; Filho VAN; Jacob-Filho W; Otoch JP; Pessoa AFM
Cell Physiol Biochem; 2023 May; 57(3):161-168. PubMed ID: 37190847
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia.
Morley JE; Baumgartner RN; Roubenoff R; Mayer J; Nair KS
J Lab Clin Med; 2001 Apr; 137(4):231-43. PubMed ID: 11283518
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenic obesity: satellite cells in the aging muscle.
Thornell LE
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):22-7. PubMed ID: 21088571
[TBL] [Abstract][Full Text] [Related]
13. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity.
Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Di Martino M; Catalano C; Lenzi A; Donini LM
Clin Nutr; 2019 Oct; 38(5):2430-2435. PubMed ID: 30792144
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner.
Huang DD; Fan SD; Chen XY; Yan XL; Zhang XZ; Ma BW; Yu DY; Xiao WY; Zhuang CL; Yu Z
Exp Gerontol; 2019 May; 119():61-73. PubMed ID: 30690066
[TBL] [Abstract][Full Text] [Related]
15. The impact of obesity on skeletal muscle strength and structure through adolescence to old age.
Tomlinson DJ; Erskine RM; Morse CI; Winwood K; Onambélé-Pearson G
Biogerontology; 2016 Jun; 17(3):467-83. PubMed ID: 26667010
[TBL] [Abstract][Full Text] [Related]
16. Health Consequences of Sarcopenic Obesity: A Narrative Review.
Roh E; Choi KM
Front Endocrinol (Lausanne); 2020; 11():332. PubMed ID: 32508753
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenic obesity: Time to meet the challenge.
Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines.
Bilski J; Pierzchalski P; Szczepanik M; Bonior J; Zoladz JA
Cells; 2022 Jan; 11(1):. PubMed ID: 35011721
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenic Obesity: Time to Meet the Challenge.
Barazzoni R; Bischoff S; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Obes Facts; 2018; 11(4):294-305. PubMed ID: 30016792
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia: characteristics, mechanisms and functional significance.
Narici MV; Maffulli N
Br Med Bull; 2010; 95():139-59. PubMed ID: 20200012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
